SEC Form 4 · accession 0001445064-16-000203
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew K Harbaugh
Officer — Sr. VP & CFO
Period of report
Feb 9, 2016
Accepted (ET)
Feb 10, 2016 · 8:47 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Feb 9, 2016 | P | 1,300 | $63.00 | A | 55,383 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 73 shares acquired between January 7, 2016 and February 5, 2016, under the Mallinckrodt employee stock purchase plan.